Cell-free RNA replication systems based on a human cell extracts-derived in vitro translation system with the encephalomyocarditisvirus RNA.

IRES-mediated translation of membrane proteins and glycoproteins in eukaryotic cell-free systems. PLoS One (2013) 0.90

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int (2009) 3.13

Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature (2005) 2.67

A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in Cap/Poly(A)-dependent translation. J Biol Chem (2002) 2.43

Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol Cell (2012) 2.19

Reconstitution reveals the functional core of mammalian eIF3. EMBO J (2007) 2.06

Dendritic BC1 RNA: functional role in regulation of translation initiation. J Neurosci (2002) 1.64

Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis. Bone (2012) 1.62

Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. J Cell Biol (2008) 1.56

Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol (2008) 1.30

Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap. Mol Cell Biol (2008) 1.27

The ELAV protein HuD stimulates cap-dependent translation in a Poly(A)- and eIF4A-dependent manner. Mol Cell (2009) 1.27

An efficient mammalian cell-free translation system supplemented with translation factors. Protein Expr Purif (2005) 1.25

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol (2012) 1.16

Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD). Nephrol Dial Transplant (2006) 1.11

Shared protein components of SINE RNPs. J Mol Biol (2002) 1.09

Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol (2010) 1.08

General RNA-binding proteins have a function in poly(A)-binding protein-dependent translation. EMBO J (2008) 1.06

Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Hypertens Res (2008) 0.99

The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone (2009) 0.98

A hybridoma-based in vitro translation system that efficiently synthesizes glycoproteins. J Biotechnol (2006) 0.96

RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes. RNA (2006) 0.96

Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different. J Virol (2003) 0.96

Cap-dependent eukaryotic initiation factor-mRNA interactions probed by cross-linking. RNA (2008) 0.96

Crystal structure of the alpha subunit of human translation initiation factor 2B. J Mol Biol (2009) 0.93

Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent. J Med Chem (2012) 0.93

Triethylborane-mediated hydrogallation and hydroindation: novel access to organogalliums and organoindiums. J Org Chem (2003) 0.88

Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan. Ther Apher Dial (2011) 0.85

Binding preference of eIF4E for 4E-binding protein isoform and function of eIF4E N-terminal flexible region for interaction, studied by SPR analysis. Biochem Biophys Res Commun (2007) 0.84

Reconstitution of the human chaperonin CCT by co-expression of the eight distinct subunits in mammalian cells. Protein Expr Purif (2011) 0.84

A human cell-derived in vitro coupled transcription/translation system optimized for production of recombinant proteins. Protein Expr Purif (2008) 0.84

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone (2008) 0.83

Crystal structure of the cambialistic superoxide dismutase from Aeropyrum pernix K1--insights into the enzyme mechanism and stability. FEBS J (2010) 0.82

An improved cell-free system for picornavirus synthesis. J Virol Methods (2007) 0.82

Cell-free protein synthesis systems with extracts from cultured human cells. Methods Mol Biol (2010) 0.82

Reconstitution of eukaryotic translation initiation factor 3 by co-expression of the subunits in a human cell-derived in vitro protein synthesis system. Protein Expr Purif (2012) 0.81

Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats. Am J Physiol Renal Physiol (2013) 0.81

N-terminally truncated GADD34 proteins are convenient translation enhancers in a human cell-derived in vitro protein synthesis system. Biotechnol Lett (2010) 0.79

Domain-dependent interaction of eukaryotic initiation factor eIF4A for binding to middle and C-terminal domains of eIF4G. J Biochem (2009) 0.78

Functional and direct interaction between the RNA binding protein HuD and active Akt1. Nucleic Acids Res (2011) 0.78

Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis. J Bone Miner Metab (2013) 0.77

Minor contribution of an internal ribosome entry site in the 5'-UTR of ornithine decarboxylase mRNA on its translation. Biochem Biophys Res Commun (2007) 0.77

Human cell extract-derived cell-free systems for virus synthesis. Methods Mol Biol (2014) 0.76

Production methods for viral particles. Biotechnol Lett (2014) 0.76

Usefulness of bone resorption markers in hemodialysis patients. Bone (2009) 0.76

Synthesis of encephalomyocarditis virus in a cell-free system: from DNA to RNA virus in one tube. Biotechnol Lett (2011) 0.75

Purification and visualization of encephalomyocarditisvirus synthesized by an in vitro protein expression system derived from mammalian cell extract. Biotechnol Lett (2012) 0.75

[Low dose estrogen replacement therapy (ERT) for postmenopausal hemodialysis (HD) patients]. Clin Calcium (2005) 0.75

[Successful treatment of MPO-ANCA associated glomerulonephritis with high dose intravenous immunoglobulin]. Nihon Naika Gakkai Zasshi (2005) 0.75

Huntingtin polyglutamine-dependent protein aggregation in reconstituted cells. ACS Synth Biol (2017) 0.75

[Advantages of human cell-derived cell-free protein synthesis systems]. Seikagaku (2009) 0.75

[Regulation of translation initiation]. Tanpakushitsu Kakusan Koso (2009) 0.75